Isis Pharma Changes “Unfortunate” Name to Avoid Confusion
The drugmaker – named after the Egyptian protector and healer goddess Isis, who was revered as a protector and healer – has been around for more than a quarter century. Credit: ManuelVelasco via iStock
By Reuters Staff
(Reuters) – After deliberating for most of the year, Isis Pharmaceuticals Inc said on Friday it would change its name to avoid being confused with the Islamist militant group known as ISIS.
The biotechnology company said it would be called Ionis Pharmaceuticals Inc from Dec. 22 and also changed its stock exchange ticker symbol to IONS from ISIS .
It’s been an ongoing discussion for most of this year , Chief Business Officer Sarah Boyce told Reuters.
When you talk about the company you want people to immediately think about the incredible work you’re doing to deliver transformational drugs to patients. not as an unfortunate namesake.
The Carlsbad, California-based company’s stock dropped about 4% on the first trading day after the Paris attacks, for which ISIS claimed responsibility.
The drugmaker – named after the Egyptian protector and healer goddess Isis, who was revered as a protector and healer – has been around for more than a quarter century.
Today it is a $7 billion company with one cholesterol drug on the market and treatments in development for a plethora of diseases, including cancer and heart conditions.
Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www.springernature.com/us ). Scientific American maintains a strict policy of editorial independence in reporting developments in science to our readers.
2016 Scientific American, a Division of Nature America, Inc.
All Rights Reserved.
Back to School
Get 50% off digital subscriptions of Scientific American and Scientific American MIND!